CSII News and Press, Cardiovascular Systems Inc.

2023-04-25 18:17:36 ET Stock in cell analysis company Cytek Biosciences ( NASDAQ: CTKB ) jumped 10.6% after hours after news that the company would be joining the S&P SmallCap 600 index. In the index, Cytek will replace Cardiovascular Systems ( CSII ), which is set...

Cytek Biosciences Set to Join S&P SmallCap 600 Cytek Biosciences Set to Join S&P SmallCap 600 PR Newswire NEW YORK , April 25, 2023 /PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P S...

2023-04-03 16:40:24 ET Cardiovascular Systems ( NASDAQ: CSII ) said it had completed the enrollment of its 2,000 patient in the Eclipse coronary atherectomy trial. The results from the are expected to be shared in the fall of 2024. Coronary atherectomy is a ...

Largest randomized coronary atherectomy trial ever conducted Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today...

NEW YORK, NY / ACCESSWIRE / April 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: INDUS Realty Trust, Inc. (NASDAQ:I...

NEW YORK, NY / ACCESSWIRE / March 19, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cardiovascular Systems, Inc. (NASDAQ...

2023-03-07 09:41:03 ET Abbott ( NYSE: ABT ) announced Tuesday that the FDA cleared what could be the first commercially available blood-based laboratory test in the U.S. for traumatic brain injury (TBI), also known as concussion. The test, which runs on the company’...

NEW YORK, NY / ACCESSWIRE / February 23, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cardiovascular Systems, Inc. (NASDAQ...

NEW YORK, NY / ACCESSWIRE / February 22, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: TravelCenters of America Inc. (NASDA...

Summary Abbott Laboratories expands its cardiovascular pipeline with the relatively small acquisition of Cardiovascular Systems, Inc. Cardiovascular Systems investors get a way out of a cash-burning stock at a decent price. The timing of the deal is opportunistic for Abbott. Abbott ...